Matthew Casbon
Sales & Marketing chez VERONA PHARMA PLC
Profil
Matthew Casbon is currently the Vice President-Sales, Marketing & Training at Verona Pharma Plc since 2022.
Previously, he worked as the Senior Director-Marketing at Salix Pharmaceuticals Ltd.
from 2010 to 2015.
He also served as the Executive Director-Marketing at Chimerix, Inc. and as the Vice President-Marketing at Zevra Therapeutics, Inc. in 2016.
Additionally, he was the Senior Vice President-Global Strategic Marketing at Niox Group Plc.
Mr. Casbon completed his undergraduate degree at West Chester University of Pennsylvania.
Postes actifs de Matthew Casbon
Sociétés | Poste | Début |
---|---|---|
VERONA PHARMA PLC | Sales & Marketing | 24/08/2022 |
Anciens postes connus de Matthew Casbon
Sociétés | Poste | Fin |
---|---|---|
NIOX GROUP PLC | Corporate Officer/Principal | 01/10/2018 |
ZEVRA THERAPEUTICS, INC. | Sales & Marketing | 01/09/2016 |
SALIX PHARMACEUTICALS, LTD. | Sales & Marketing | 01/01/2015 |
CHIMERIX, INC. | Sales & Marketing | - |
Formation de Matthew Casbon
West Chester University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
CHIMERIX, INC. | Health Technology |
ZEVRA THERAPEUTICS, INC. | Health Technology |
VERONA PHARMA PLC | Health Technology |
NIOX GROUP PLC | Health Services |
Entreprise privées | 1 |
---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |